Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial.

The disposition index tended to be increased after valsartan treatment compared with placebo, although this did not reach statistical significance (5 ± 14 vs. −30 ± 18 [nmol ⋅ min −1 ⋅ L −1 ] × [mg ⋅ kg −1 ⋅ min −1 ], P = 0.12, respectively).

also in 111,027 other papers